Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
HutchMed’s H1 2022 Oncology Sales Surge 82% on Strong Product Performance
February 17, 2025
Company
Drug
Lion TCR Enrolls First Patient in LioCyx-M004 Study for HBV-Related Liver Cancer
February 17, 2025
Company
Drug
Grand Pharma’s TLX591-CDx and TLX250-CDx Advance in China with NMPA Review
February 17, 2025
Company
Deals
OriginCell Therapeutics Raises USD 120M in Series B for Tumor Immunotherapy Pipeline
February 18, 2025
Company
Deals
Fosun Pharma to Hike Aitrox Stake to 72.63% for USD 61M
February 17, 2025
Company
Deals
GluBio Pharma Raises USD 22M in Series A+ Round to Advance TPD Pipeline
February 17, 2025
Company
Deals
Ribo Life Science Raises USD 40M in Series E1 Round for siRNA Drug Development
February 17, 2025
Company
Deals
BridGene Biosciences Completes USD 38.5M Series B Round with China Funds
February 17, 2025
Company
Deals
Basecare Medical Sells 35% Stake in Cellpro Biotech for USD 9.5M
February 17, 2025
Company
Drug
Sanjin Pharma’s Subsidiary Gets FDA Nod for BC007 Cancer Drug Trial
February 17, 2025
Company
Deals
Pica Partners with BrainCo to Launch ADHD Product in China
February 17, 2025
Hospital
Policy / Regulatory
NHC Designates National Mental Illness Medical Centers in Beijing and Shanghai
February 18, 2025
1
2
…
1,161
1,162
1,163
1,164
1,165
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
